Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Corixa [CRXA] - cancer vaccines -- Ignore unavailable to you. Want to Upgrade?

To: berblady who wrote (50)	3/4/2001 5:54:06 PM
From: dmkst1	Read Replies (1) \| Respond to of 222

berblady that info was available on the IDPH conference call in late jan/early feb - at that time IDPH said they were going to have their mid cycle review in middle of feb and that review dates can be set after that - they also discussed the mechanism for the cancellation of the meeting being that the contents of the meeting have to be posted in the federal register a certain time period before the meeting - the FDA did not send any notice to the federal reigster about what would happen at that meeting and therefore the meeting had to be cancelled.